These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30377747)

  • 1. Treatment of ischemic stroke beyond 3 hours: is time really brain?
    von Kummer R
    Neuroradiology; 2019 Feb; 61(2):115-117. PubMed ID: 30377747
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy for acute ischemic stroke.
    Perl J; Samples SD
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):115-21. PubMed ID: 11981798
    [No Abstract]   [Full Text] [Related]  

  • 3. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

  • 4. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Kleindorfer DO; Khatri P; Katzan I
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    Whitcomb DS
    Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
    [No Abstract]   [Full Text] [Related]  

  • 6. rtPA in acute stroke patients with history of cognitive impairment: do not hesitate to treat.
    Román GC; Hakim AM
    Neurology; 2014 Jun; 82(23):2044-5. PubMed ID: 24827496
    [No Abstract]   [Full Text] [Related]  

  • 7. IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon?
    Barrett KM; Gottesman RF
    Neurology; 2016 Jul; 87(2):132-3. PubMed ID: 27306635
    [No Abstract]   [Full Text] [Related]  

  • 8. Does "time is brain" also mean "time is clot"? Time dependency of tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.
    Tsivgoulis G; Alexandrov AV
    Stroke; 2014 Sep; 45(9):2555-6. PubMed ID: 25104843
    [No Abstract]   [Full Text] [Related]  

  • 9. The Acute Stroke Care Revolution: Enhancing Access to Therapeutic Advances.
    Josephson SA; Kamel H
    JAMA; 2018 Sep; 320(12):1239-1240. PubMed ID: 30208486
    [No Abstract]   [Full Text] [Related]  

  • 10. Breaking the 3 h barrier for treatment of acute ischaemic stroke.
    Donnan GA; Davis SM
    Lancet Neurol; 2008 Nov; 7(11):981-2. PubMed ID: 18940690
    [No Abstract]   [Full Text] [Related]  

  • 11. Reimbursement for thrombectomy devices in patients who are ineligible for intravenous tissue-type plasminogen activator.
    Broderick JP; Tomsick TA;
    Stroke; 2013 May; 44(5):1215-6. PubMed ID: 23598521
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed.
    Demaerschalk BM
    Stroke; 2007 Aug; 38(8):2215-6. PubMed ID: 17641237
    [No Abstract]   [Full Text] [Related]  

  • 14. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE
    Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 16. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telephone consultations for tissue plasminogen activator administration in acute stroke.
    Sattin JA
    Continuum (Minneap Minn); 2014 Apr; 20(2 Cerebrovascular Disease):429-35. PubMed ID: 24699491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
    Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of alteplase beyond 3 hours of ischemic stroke onset.
    Powers CM
    Adv Emerg Nurs J; 2011; 33(1):65-70. PubMed ID: 21317699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.